Eva Morfeldt

Public Health Agency of Sweden — Sweden

Medicine · Health Sciences

25h-index3.6kcitations44works13.42yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pneumonia and Respiratory Infections(29), Respiratory viral infections research(21), Bacterial Infections and Vaccines(17), Antimicrobial Resistance in Staphylococcus(14), Pneumocystis jirovecii pneumonia detection and treatment(6)

Publications44 total

Quantifying the impact of the COVID-19 pandemic on invasive bacterial diseases across 27 countries and territories: prospective surveillance by the IRIS Consortium
2025· 1 citedOpen Access
Broth microdilution susceptibility testing reveals underestimation of resistance to penicillin and high levels of resistance to ampicillin of Streptococcus pneumoniae clinical isolates in Sweden
Clinical Microbiology and Infection·2025
The importance of microbiology reference laboratories and adequate funding for infectious disease surveillance
The Lancet Digital Health·2024· 12 citedOpen Access
Serotype distribution of remaining invasive pneumococcal disease after extensive use of ten-valent and 13-valent pneumococcal conjugate vaccines (the PSERENADE project): a global surveillance analysis
The Lancet Infectious Diseases·2024· 52 citedOpen Access
Global Serotype Distribution of Remaining Invasive Pneumococcal Disease after Extensive Use of Pcv10/13: The Pserenade Project
SSRN Electronic Journal·2024· 2 citedOpen Access
Trends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS Consortium
The Lancet Digital Health·2023· 148 citedOpen Access
Sustained reductions in life-threatening invasive bacterial diseases during the first two years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries participating in the IRIS Consortium
2022Open Access
Bacterial meningitis: Aetiology, risk factors, disease trends and severe sequelae during 50 years in Sweden
Journal of Internal Medicine·2022· 30 citedOpen Access
Serotype Replacement after Introduction of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines in 10 Countries, Europe
Emerging infectious diseases·2021· 155 citedOpen Access
Changes in Invasive Pneumococcal Disease Caused by Streptococcus pneumoniae Serotype 1 Following Introduction of PCV10 and PCV13: Findings from the PSERENADE Project
Bern Open Repository and Information System (University of Bern)·2021Open Access
Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data
Bern Open Repository and Information System (University of Bern)·2021Open Access
Chronic Disease and Immunosuppression Increase the Risk for Nonvaccine Serotype Pneumococcal Disease: A Nationwide Population-based Study
Clinical Infectious Diseases·2021· 16 citedOpen Access
Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data
The Lancet Digital Health·2021· 515 citedOpen Access
Changes in Invasive Pneumococcal Disease Caused by Streptococcus pneumoniae Serotype 1 following Introduction of PCV10 and PCV13: Findings from the PSERENADE Project
Microorganisms·2021· 23 citedOpen Access
The Invasive Respiratory Infection Surveillance (IRIS) Initiative reveals significant reductions in invasive bacterial infections during the COVID-19 pandemic
2020· 9 citedOpen Access
Serotype and molecular diversity of nasopharyngeal Streptococcus pneumoniae isolates from children before and after vaccination with the ten-valent pneumococcal conjugate vaccine (PCV10) in Ethiopia
BMC Infectious Diseases·2019· 17 citedOpen Access
Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination
Thorax·2018· 165 citedOpen Access
Reply to Theilacker et al
Clinical Infectious Diseases·2017· 1 citedOpen Access
External Quality Assurance for Laboratory Identification and Capsular Typing of Streptococcus pneumoniae
Scientific Reports·2017· 11 citedOpen Access
Comparison of the Impact of Pneumococcal Conjugate Vaccine 10 or Pneumococcal Conjugate Vaccine 13 on Invasive Pneumococcal Disease in Equivalent Populations
Clinical Infectious Diseases·2017· 147 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Birgitta Henriques‐Normark(23), Jana Kozáková(14), Carmen Muñoz‐Almagro(14), Tine Dalby(13), Shamez Ladhani(13), Emmanuelle Varon(12), Mary Corcoran(11), Stefanie Desmet(11), Markus Hilty(11), Karl G. Kristinsson(11), Anne von Gottberg(11), Pavla Křížová(10), Kevin J Scott(10), Anna Skoczyńska(9), Hans‐Christian Slotved(9), Nina M. van Sorge(9), Norman K. Fry(8), Assaf Rokney(8), M. Ron(8), Lotta Siira(8)